VIP and asthma: Athari et al. formulatedPLGA nanoparticles(NPs) encapsulating vasoactive intestinal peptide (VIP), a compoundrecognized for its antispasmodic and anti-inflammatory properties,positioning it as a promising alternative for asthma management.